BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23707254)

  • 21. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
    Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
    Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Sokolov VB; Grigoriev VV; Serebryakova OG; Vikhareva EA; Aksinenko AY; Barreto GE; Aliev G; Bachurin SO
    Sci Rep; 2015 Aug; 5():13164. PubMed ID: 26281952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinesterase inhibitors: a patent review (2007 - 2011).
    de los Ríos C
    Expert Opin Ther Pat; 2012 Aug; 22(8):853-69. PubMed ID: 22764681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors.
    Andreani A; Burnelli S; Granaiola M; Guardigli M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Rizzoli M; Varoli L; Roda A
    Eur J Med Chem; 2008 Mar; 43(3):657-61. PubMed ID: 17624631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
    Więckowska A; Bajda M; Guzior N; Malawska B
    Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, in vitro evaluation and preliminary SAR studies of N-(2-(heteroaryloxy)propyl)phenothiazines against Rhipicephalus microplus cattle tick.
    Maldonado-Domínguez M; Alavez-Rosas D; Aguilar H; Méndez-Stivalet JM; Romero-Ávila M; Flores-Pérez B; Ibarra F; Alcalá-Canto Y; Vera-Montenegro Y; García-Ortega H
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3069-72. PubMed ID: 24878192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
    Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
    J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
    Melchiorre C; Andrisano V; Bolognesi ML; Budriesi R; Cavalli A; Cavrini V; Rosini M; Tumiatti V; Recanatini M
    J Med Chem; 1998 Oct; 41(22):4186-9. PubMed ID: 9784091
    [No Abstract]   [Full Text] [Related]  

  • 33. [3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites.
    Reynolds IJ; Miller RJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1025-31. PubMed ID: 2849655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.
    Huang G; Kling B; Darras FH; Heilmann J; Decker M
    Eur J Med Chem; 2014 Jun; 81():15-21. PubMed ID: 24819955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.
    Dumitriu GM; Ghinet A; Bîcu E; Rigo B; Dubois J; Farce A; Belei D
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3180-5. PubMed ID: 24856060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
    Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P
    Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
    Piazzi L; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
    Bioorg Med Chem; 2007 Jan; 15(1):575-85. PubMed ID: 17008100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.